Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Flutamide rarely causes liver toxicity in prostate cancer patients.

The drug combination was safe and showed promise in treating advanced tumors.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

A fast and accurate method was developed to measure alfuzosin and dutasteride in human plasma.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Pexidartinib often causes liver issues and fatigue, especially in women.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Oral bicalutamide is safe and effective for female hair loss.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Nilotinib can cause generalized keratosis pilaris.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

A reliable method was created to measure dutasteride and related molecules in capsules.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Kūlaris improved quality of life for acne sufferers without side effects.